[D-Leu-4]-OB 3
Alternative Names: OB 3Latest Information Update: 20 Jan 2003
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 22 Mar 2001 Preclinical development for Obesity in USA (Unknown route)